date:Jul 20, 2012
rchase and $7.5 million allocated to the real estate property.
The AMT acquisition is complementary to the Innophos acquisition of Kelatron last year, according to Cranbury-based Innophos, a producer of specialty ingredients. The combined businesses of Kelatron, which manufactures bioactive mineral nutrients used in nutritional and dietary supplements, and AMT expands the Innophos presence in U.S. bioactive mineral ingredients, with annual revenues of about $30 million.
The acquisition of AMT re